Finch Therapeutics Group, Inc. ( FNCH) - Key Metrics
FNCH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0 | -$3.01 | -$2.94 | -$2.94 |
| 2024Q1 | $0 | -$2.41 | -$2.72 | -$2.72 |
| 2023Q4 | $1.77 | -$1.89 | -$2.31 | -$2.30 |
| 2023Q3 | $0 | -$1.51 | -$3.28 | -$3.28 |
| 2023Q2 | $0 | -$4.33 | -$5.71 | -$5.71 |
FNCH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | 0% | -0.11 |
| 2024Q1 | 0% | -0.26 |
| 2023Q4 | 0% | -0.48 |
| 2023Q3 | 0% | -0.86 |
| 2023Q2 | 0% | -0.49 |
FNCH
Price: $10.20
52 week price:
Earnings Per Share: -8.80 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 136300
Market Capitalization: 14.8 million